Eldorado Gold
EGO
36.66
-1.88
-4.88%
Eldorado Gold
US · EGO
#1468 by market cap
Listed 2003
36.66
-1.88
-4.88%
Live - 5344 symbols - heartbeat 122s ago
· 2026-10-08 07:45
Pre-market
36.25
-1.11%
After-hours
37.00
+0.93%
- Market cap
- 9.58B
- P/E (TTM)i
- 13.05
- P/Bi
- 1.40
- EPSi
- 2.47
- Div yieldi
- 0.41%
- 52W posi
- 47%
Reader sentiment
Are you bullish or bearish on EGO?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.77, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +37.52% YoY
Margins
- Gross margin
- 48.09%
- Operating margin
- 40.97%
- Net margin
- 28.13%
Key ratios & quality
- Enterprise valuei
- 9.99B
- Altman Z-Scorei
- 2.77
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 459.02M | 617.82M | 1.03B | 940.91M | 871.98M | 1.01B | 1.32B | 1.82B |
| Gross profit | 83.45M | 127.96M | 363.42M | 292.77M | 171.69M | 270.07M | 507.93M | 867.25M |
| Selling & admin expenses | 57.35M | 42.29M | 42.07M | 45.78M | 53.74M | 54.21M | 51.70M | 63.84M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | -26.29M | 51.16M | 293.29M | 213.90M | 61.95M | 173.04M | 416.31M | 738.86M |
| Pretax profit | -466.13M | 113.46M | 206.33M | 157.46M | 11.86M | 163.37M | 435.39M | 544.32M |
| Tax | -86.50M | 39.77M | 82.36M | 138.07M | 61.22M | 57.58M | 134.76M | 22.07M |
| Net profit | -379.63M | 73.69M | 117.62M | -135.71M | -426.85M | 101.38M | 286.96M | 504.30M |
| Basic EPS | -2 | 1 | 1 | -1 | -2 | 1 | 1 | 3 |
| Diluted EPS | -2.28 | 0.50 | 0.71 | -0.75 | -1.93 | 0.54 | 1.41 | 2.47 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 355.25M | 451.72M | 434.73M | 577.16M | 532.43M | 487.46M |
| Gross profit | 146.77M | 223.60M | 207.76M | 289.12M | 290.22M | 248.43M |
| Selling & admin expenses | 12.44M | 14.79M | 16.31M | 20.30M | 14.77M | 14.95M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 123.20M | 196.90M | 172.53M | 249.18M | 261.43M | 212.44M |
| Pretax profit | 42.26M | 172.22M | 110.09M | 219.74M | 246.75M | 227.17M |
| Tax | -32.61M | 33.30M | 53.92M | -32.54M | 111.01M | 54.50M |
| Net profit | 73.53M | 134.80M | 55.05M | 240.91M | 135.74M | 172.67M |
| Basic EPS | 0 | 1 | 0 | 1 | 1 | 1 |
| Diluted EPS | 0.35 | 0.67 | 0.27 | 1.18 | 0.68 | 0.68 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 514.70M | 435.86M | 754.10M | 728.24M | 632.46M | 930.41M | 1.48B | 1.45B |
| Cash & ST investments | 295.53M | 184.85M | 511.19M | 481.49M | 314.87M | 543.31M | 995.73M | 869.36M |
| Inventory | 137.89M | 163.23M | 164.14M | 178.16M | 198.87M | 235.89M | 279.00M | 297.17M |
| Total assets | 4.63B | 4.65B | 4.93B | 4.93B | 4.46B | 4.99B | 5.84B | 6.73B |
| Total current liabilities | 141.70M | 221.72M | 262.04M | 206.65M | 210.94M | 274.22M | 412.17M | 789.07M |
| Short-term debt | 2.98M | 76.58M | 77.96M | 7.23M | 4.78M | 5.02M | 4.69M | 53.99M |
| Long-term debt | 595.98M | 413.07M | 434.47M | 489.76M | 498.09M | 641.69M | 923.00M | 1.23B |
| Total liabilities | 1,281,840,000.00 | 1,175,107,000.00 | 1,243,500,000.00 | 1,290,812,000.00 | 1,257,048,000.00 | 1,475,669,000.00 | 1,947,146,000.00 | 2,444,218,000.00 |
| Total equity | 3.35B | 3.47B | 3.69B | 3.64B | 3.20B | 3.51B | 3.89B | 4.28B |
| Retained earnings | -2.31B | -2.23B | -2.10B | -2.24B | -2.59B | -2.49B | -2.19B | -1.57B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.47B | 1.62B | 1.56B | 1.45B | 1.19B | 1.18B |
| Cash & ST investments | 978.14M | 1.08B | 1.04B | 869.36M | 629.72M | 554.56M |
| Inventory | 276.85M | 290.36M | 289.49M | 297.17M | 327.19M | 415.64M |
| Total assets | 5.95B | 6.30B | 6.49B | 6.73B | 6.70B | 10.25B |
| Total current liabilities | 472.51M | 501.85M | 557.96M | 789.07M | 732.54M | 897.97M |
| Short-term debt | 5.11M | 5.94M | 5.76M | 53.99M | 52.51M | 237.12M |
| Long-term debt | 940.97M | 1.16B | 1.27B | 1.23B | 1.18B | 1.52B |
| Total liabilities | 1,966,817,000.00 | 2,217,357,000.00 | 2,395,680,000.00 | 2,444,218,000.00 | 2,378,691,000.00 | 3,387,762,000.00 |
| Total equity | 3.98B | 4.09B | 4.09B | 4.28B | 4.32B | 6.86B |
| Retained earnings | -2.02B | -1.88B | -1.82B | -1.57B | -1.43B | -1.28B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 67.54M | 165.83M | 469.98M | 362.37M | 211.00M | 383.31M | 655.61M | 742.16M |
| Depreciation & amortization | 105.73M | 155.33M | 220.22M | 201.94M | 242.39M | 264.33M | 254.99M | 260.51M |
| Free cash flow | -200.89M | -52.53M | 281.12M | 80.28M | -78.86M | -29.34M | 31.01M | -169.13M |
| Dividends paid | -- | -- | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock buybacks / issuance | -2.11M | 40.07M | 92.44M | 14.55M | 132.00K | 164.22M | 12.15M | -206.02M |
| Ending cash balance | 286.31M | 177.74M | 451.96M | 481.33M | 279.74M | 540.47M | 856.80M | 869.36M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 130.60M | 158.29M | 170.06M | 283.21M | 141.39M | 149.54M |
| Depreciation & amortization | 60.62M | 66.42M | 63.34M | 70.13M | 54.45M | 54.70M |
| Free cash flow | -33.41M | -32.91M | -73.94M | -25.12M | -174.58M | -320.07M |
| Dividends paid | 0 | 0 | 0 | 0 | -14.90M | -19.59M |
| Stock buybacks / issuance | 503.00K | -41.79M | -81.17M | -83.56M | -86.35M | -2.43M |
| Ending cash balance | 978.14M | -- | 1.04B | 869.36M | 629.72M | -- |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -10.45 | 2.41 | 2.97 | -3.79 | -10.45 | 3.11 | 7.80 | 12.41 |
| ROA %i | -7.45 | 1.74 | 2.19 | -2.77 | -7.54 | 2.22 | 5.34 | 8.08 |
| ROIC %i | -8.82 | 2.71 | 3.50 | -2.15 | -8.56 | 2.76 | 6.36 | 9.64 |
| 5-year avg ROE %i | -10.47 | -10.38 | -2.86 | -1.71 | -3.74 | -1.03 | 0.05 | 1.82 |
| EBIT margin %i | -100.62 | 25.47 | 22.08 | 23.25 | 5.40 | 19.19 | 34.42 | 31.72 |
| FCF / sales %i | -- | -- | 22.80 | 8.53 | -- | -- | 1.17 | -- |
| Current ratioi | 3.63 | 1.97 | 2.88 | 3.52 | 3.00 | 3.39 | 3.60 | 1.83 |
| Quick ratioi | 2.55 | 1.12 | 2.17 | 2.58 | 1.81 | 2.35 | 2.73 | 1.46 |
| Debt / assetsi | 13.08 | 10.86 | 10.69 | 10.38 | 11.55 | 13.21 | 16.07 | 19.17 |
| LT debt / equityi | 18.35 | 12.54 | 12.32 | 14.13 | 15.93 | 18.58 | 23.94 | 28.88 |
| Interest coveragei | -108.32 | 3.61 | 4.48 | 3.23 | 1.34 | 6.36 | 22.64 | 20.67 |
| Revenue CAGR (3Y) %i | -1.44 | 12.49 | 37.91 | 27.18 | 12.26 | -0.54 | 11.94 | 27.43 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -5.71 | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -27.17 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 8.65 | 10.57 | 9.44 | 12.41 | 13.75 | 11.06 |
| ROA %i | 5.95 | 7.09 | 6.17 | 8.08 | 9.03 | 7.32 |
| ROIC %i | 7.13 | 8.89 | 7.31 | 9.64 | 10.87 | 9.15 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 31.63 | 34.69 | 31.45 | 31.72 | 35.86 | 41.79 |
| FCF / sales %i | 1.05 | -- | -- | -- | -- | -- |
| Current ratioi | 3.12 | 3.23 | 2.79 | 1.83 | 1.62 | 1.31 |
| Quick ratioi | 2.34 | 2.62 | 2.20 | 1.46 | 1.18 | 0.85 |
| Debt / assetsi | 16.06 | 18.62 | 19.89 | 19.17 | 18.57 | 17.20 |
| LT debt / equityi | 23.82 | 28.50 | 31.32 | 28.88 | 27.59 | 22.24 |
| Interest coveragei | -- | 21.04 | 20.04 | 20.67 | -- | 21.67 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Gold revenue - dore is the largest reported line at 67.77% of revenue, across 8 reported segments.
- Gold revenue - concentrate follows at 27.16%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Gold revenue - dore67.77%
Gold revenue - concentrate27.16%
Silver revenue - concentrate4.50%
Zinc concentrate1.08%
Lead concentrate0.87%
Silver revenue - dore0.85%
Quote time 2026-10-08 07:45:22 · For reference only, not investment advice and not tailored to your situation.